InvestorInformation

Latest Annoucements

  • Disclosure of material event – Resignation of Director

    27.01.2022 Read More
  • Press Release in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited

    27.01.2022 Read More
  • Disclosure of material event – Acquisition of Brands and Related Assets from Sanzyme Private Limited

    27.01.2022 Read More
  • Schedule of Investors / Analysts’ call with Management on 27.01.2022 and Registration Log-in details for the same

    26.01.2022 Read More
  • Press Release regarding the launch of Molupiravir for the Indian market

    29.12.2021 Read More
  • Q2 Results 2021-CNBC TV18

    15.11.2021 Read More
  • Q2 FY22 Press Release

    11.11.2021 Read More
  • Q2 FY22 Investor Presentation

    11.11.2021 Read More
  • Q2 FY22 Results Sheet

    11.11.2021 Read More
  • Grant of options under ESOS Scheme

    01.10.2021 Read More
  • Change in Key Managerial Personnel

    01.10.2021 Read More
  • Disclosure of Material events/ information – Submission of application to Stock Exchanges for reclassification

    17.09.2021 Read More
  • AGM Recording

    15.09.2021 Read More
  • Disclosure of material event/information – Re-classification of status from promoter to public of certain promoters/promoter group members

    10.09.2021 Read More
  • Disclosure of material event/information – Appointment of Statutory Auditor

    10.09.2021 Read More
  • Disclosure of material event/information – Proceedings of the Annual General Meeting

    10.09.2021 Read More
  • Result of voting at Annual General Meeting

    10.09.2021 Read More
  • Disclosure of material event/information – Resignation of Chief Financial Officer

    07.09.2021 Read More
  • Presentation made to Investors – 12.08.2021

    12.08.2021 Read More
  • Unaudited Financial Results 31.12.2020

    19.07.2021 Read More
  • Intimation of Record Date

    19.07.2021 Read More
  • Press Release for Unaudited Financial Results – 31.12.2020

    19.07.2021 Read More
  • Presentation made to Investors – 10.02.2021

    19.07.2021 Read More
  • Schedule of meeting with institutional investors

    19.07.2021 Read More
  • Presentation made to Investors – 02.03.2021

    19.07.2021 Read More
  • Outcome of Board meeting

    19.07.2021 Read More
  • Institution of new Employee Stock Option Scheme

    19.07.2021 Read More
  • Launch of new dedicated division “RENOVA” to enter Nephrology segment in India

    19.07.2021 Read More
  • Disclosure of receipt of requests from the promoters/ promoter group members seeking re-classification of status as public

    19.07.2021 Read More
  • Notice of Board Meeting

    19.07.2021 Read More
  • Recommendation of final dividend

    19.07.2021 Read More
  • Schedule of Investors/ Analysts’ call with management on 15.06.2021 and Registration/Log-in details for the same

    19.07.2021 Read More
  • Audited Financial Results 31.03.2021

    19.07.2021 Read More
  • Press Release for Audited Financial Results – 31.03.2021

    19.07.2021 Read More
  • JBCPL Q4 FY21 Earnings Call Transcript

    19.07.2021 Read More
  • Instructions

    19.07.2021 Read More
  • Postal Ballot Form

    19.07.2021 Read More
  • Disclosure of material event/information – 02.07.2021

    19.07.2021 Read More
  • Newspaper advertisement for Postal Ballot

    19.07.2021 Read More
  • Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2021

    15.07.2021 Read More
  • Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2021

    15.07.2021 Read More

Financial Information

Know More

Shareholder's corner

Know More

CEO's Desk

We are BIG enough to create a positive impact for patients and healthcare providers, we are small enough to still care…

Know More

IR & Shareholders Contact

For Shareholders:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbcpl.com

For Transfer/Transmission of Shares:
Datamatics Business Solutions Ltd.
Plot No. B 5, Part B Crosslane,
MIDC, Andheri (East), Mumbai 400 093.
India.

Contact Person: Mr. Satish Patil
Tel No. (022) 6671 2001-06
Fax No. (022) 6671 2011
Email: corpequity@dfssl.com

Nodal Officer for the Purpose of Coordination with IEPF Authority:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbcpl.com